Startseite
English
Erweiterte Suche
Durchblättern nach ...
Publikationen im Überblick
Ansprechpartner
Hilfe
DOI
PMC
 |
|
Open Access Green möglich sobald Postprint bei der ZB eingereicht worden ist.
Early evaluation and value-based pricing of regenerative medicine technologies.
Regen. Med. 8, 747-758 (2013)
Since the first pioneering scientists explored the potential of using human cells for therapeutic purposes the branch of regenerative medicine has evolved to become a mature industry. The focus has switched from 'what can be done' to 'what can be commercialized'. Timely health economic evaluation supports successful marketing by establishing the value of a product from a healthcare system perspective. This article reports results from a research project on early health economic evaluation in collaboration with developers, clinicians and manufacturers. We present an approach to determine an early value-based price for a new treatment of cartilage defects of the knee from the area of regenerative medicine. Examples of using evaluation results for the purpose of business planning, market entry, preparing the coverage decision and managed entry are discussed.
Altmetric
Weitere Metriken?
Zusatzinfos bearbeiten
[➜Einloggen]
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Business planning; Commercialization; early evaluation; Innovation management; Market access; Pricing; Reimbursement; Autologous Chondrocyte Implantation ; Osteochondral Defects ; Cartilage Lesions ; Randomized-trial ; Decision-making ; Stem-cells ; Knee ; Microfracture ; Challenges ; Industry
ISSN (print) / ISBN
1746-0751
e-ISSN
1746-076X
Zeitschrift
Regenerative Medicine
Quellenangaben
Band: 8,
Heft: 6,
Seiten: 747-758
Verlag
Future Medicine
Nichtpatentliteratur
Publikationen
Begutachtungsstatus
Peer reviewed